This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Journal and News Scan

Source: The Annals of Thoracic Surgery
Author(s): Neel P. Chudgar, MD Roger Zhu, MD Katherine D. Gray, MD Ryan Chiu, MD, MBA Araceli Delacruz Carrera, DNP Samuel J. Lang, MD Dimitrios V. Avgerinos, MD, PhD Charles A. Mack, MD

Readmission after coronary artery bypass grafting (CABG) is linked with negative outcomes and raised cost. We evaluated the impact of a high-value care discharge protocol on readmission, length of stay (LOS), and discharge destination in patients undergoing isolated CABG.

Source: Circulation Research
Author(s): Olurotimi O. Mesubi , Mark E. Anderson

A brief but comprehensive editorial on nuances of the links between atrial fibrillation and heart failure, apropos a trial we have commented recently on, by the Johns Hopkins team that develops the calmodulin-dependent protein kinase II inhibitor molecules 


Source: Brazilian Journal of Cardiovascular Surgery
Author(s): Kevin Pilarczyk1,2, MD; Vinicius Nina3,4, MD; Lynn Boshkov5, MD; Barbara Ferdman6, MD; Emily A. Farkas7, MD; Nicole Burnham8, MD; Renzo Cifuentes9, Daniel Ntogwiachu10, MD; Aubyn Marath4, MD

Every year, millions of people are dying and millions more are disabled due to treatable cardiovascular diseases. Surgical capacity is unevenly distributed around the world and disproportionally affects populations in low- and middle- income countries (LMICs). COVID-19 increases barriers for access to cardiac surgical care, and high- level action is urgently needed to not only expand cardiac services around the world but also to ensure health systems are strengthened so that cardiac patients can be effectively managed during and after the pandemic. The primary aim of this systematic review is to provide perioperative strategies to help restore or preserve cardiovascular services in LMICs under threat from financial and personnel constraints imposed by the pandemic.


Source: Circulation Research
Author(s): Luca Zanoli, Agostino Gaudio, Dimitri P. Mikhailidis, Niki Katsiki, Niccolò Castellino, Lorenzo Lo Cicero, Giulio Geraci, Concetto Sessa, Letizia Fiorito, Francesca Marino, Maria Antonietta Di Rosolini, Michele Colaci, Antonio Longo, Arturo Montineri, Lorenzo Malatino , Pietro Castellino and Methuselah Study Group

Interesting case-control study on variations of aortovascular compliance 

Source: World Journal for Pediatric and Congenital Heart Surgery
Author(s): Levy ER, Dearani JA, Blumenthal J, Johnson JN, Overman DM, Stephens EH, Chiotos K.

This timely article addresses the interface between the Covid pandemic and patients with congenital heart diseases.  It offers responses to a variety of questions related to: vaccinations, passive immunization, Covid testing, antivirals,  immunomodulatory therapy, and transplant status.

Source: Cardiovascular Business
Author(s): Dave Fornell

Cardiothoracic surgeon Igor Mokryk, MD, PhD, spent last week taking his family on a 370-mile journey from Kyiv, Ukraine, to the Polish border. While there they joined aound 2 million other war refugees in Poland. After this he drove back to war-torn Kyiv to continue at his post and treat patients at the Heart Institute of the Ministry of Health of Ukraine. 

Source: tctMD
Author(s): Michael O'Riordan

Several surgical associations have given a new statement in response to the new Valve Academic Research Consortium (VARC) definitions for aortic valve clinical studies. They took issue with a few things, most notably, rehospitalization, bleeding, and myocardial infarction.

Source: Medical News Today
Author(s): Katharine Lang

Doctors at Duke University Hospital have successfully transplanted a heart combined with a processed allogeneic thymus tissue. The recipient was a baby who of six months and has now just celebrated his first birthday. The infant now seems to be producing the immune cells needed to reduce or even eliminate the need for long-term treatment with antirejection drugs.

Source: European Journal of Cardio-Thoracic Surgery
Author(s): Patrick O Myers, MD, Victor Dayan, MD, Wilson Y Szeto, MD, Vinod H Thourani, MD, S Chris Malaisrie, MD, Marc R Moon, MD, Richard L Prager, MD, Minoru Ono, MD, Yutaka Okita, MD, Nicholas Freemantle, PhD, Milan Milojevic, MD, PhD

This is a joint position statement from EACTS, LACES, ASCVTS, AATS, and STS regarding the VARC-3 Definitions for Aortic Valve Clinical Research.

Source: The Annals of Thoracic Surgery
Author(s): Niv Ad, MD Paul S. Massimiano, MD Anthony J. Rongione, MD Bradley Taylor, MD, MPH Stefano Schena, MD Diane Alejo, BA Clifford E. Fonner, BA Rawn Salenger, MD Glenn Whitman, MD Thomas S. Metkus, MD Sari D. Holmes, PhD

The link between blood transfusion and adverse outcome is well noted in cardiac surgery. However, the rising significance of each unit transfused, whether red blood cell (RBC) or non-RBC, is not fully known. This study looked at the relationship of patient outcomes with the type and number of blood product units transfused.